Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MANNKIND CORPMNKD · Entity 4792 | Chief Technology Officer | August 27, 2022 | August 30, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MANNKIND CORP
Report date August 27, 2022 · Filed August 30, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.01 Par ValueSEC Table I · non-derivative | Direct | 745,233 |
Reported balance
After 2022-08-27 transaction · row 1
1 source rowRow 1 · 2022-08-27 · Tax withholding · Disposed 12,813 · Balance 745,233 F1: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 27, 2022 Filed Aug 30, 2022 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 12,813 | $3.73 | $47,792.49 |
DisclosureSEC source: 0001209191-22-047946 · doc4.xml · nonDerivative · entry 1 Kocinsky Joseph · CIK 0001655595 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 745,233 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| May 18, 2022 Filed May 21, 2022 00:00 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 5,383 | $3.19 | $17,171.77 |
DisclosureSEC source: 0001209191-22-031204 · doc4.xml · nonDerivative · entry 1 Kocinsky Joseph · CIK 0001655595 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 758,046 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| May 10, 2022 Filed May 13, 2022 00:00 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 110,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028673 · doc4.xml · nonDerivative · entry 2 Kocinsky Joseph · CIK 0001655595 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 763,429 F3 · shares: The restricted stock unit will vest on May 10, 2025 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on May 10, 2022. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from May 10, 2022 until May 10, 2025 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| May 10, 2022 Filed May 13, 2022 00:00 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028673 · doc4.xml · nonDerivative · entry 1 Kocinsky Joseph · CIK 0001655595 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 653,429 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. Read SEC document |
| August 27, 2021 Filed Aug 28, 2021 01:01 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 9,983 | $4.91 | $49,016.53 |
DisclosureSEC source: 0001209191-21-053769 · doc4.xml · nonDerivative · entry 1 Kocinsky Joseph · CIK 0001655595 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 563,429 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:00 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 79,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034460 · doc4.xml · nonDerivative · entry 2 Kocinsky Joseph · CIK 0001655595 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 573,412 F3 · shares: The restricted stock unit will vest on May 17, 2024 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on May 17, 2021. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from May 18, 2021 until May 17, 2024 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:00 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 68,895 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034460 · doc4.xml · nonDerivative · entry 1 Kocinsky Joseph · CIK 0001655595 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 494,412 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 23:08 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048848 · doc4.xml · nonDerivative · entry 2 Kocinsky Joseph · CIK 0001655595 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,517 F3 · shares: The restricted stock unit will vest on May 22, 2023 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on August 27, 2020. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from August 27, 2020 until May 22, 2023 related to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 23:08 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 164,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048848 · doc4.xml · nonDerivative · entry 1 Kocinsky Joseph · CIK 0001655595 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,517 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 11:00 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option (right to buy) · Derivative | 37,525 | $1.42 Strike: $1.42 | $53,285.50 |
DisclosureSEC source: 0001209191-20-013628 · doc4.xml · derivative · entry 2 Kocinsky Joseph · CIK 0001655595 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,525 Underlying: Stock Options · 37,525 shares Expires 2027-05-25 F2 · kind: On May 25, 2017, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On February 25, 2020, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 11:00 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option (right to buy) · Derivative | 20,000 | $4.55 Strike: $4.55 | $91,000.00 |
DisclosureSEC source: 0001209191-20-013628 · doc4.xml · derivative · entry 1 Kocinsky Joseph · CIK 0001655595 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Stock Options · 20,000 shares Expires 2026-05-19 F1 · kind: On May 19, 2016, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On February 25, 2020, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:25 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option (right to buy) · Derivative | 234,000 | $1.32 Strike: $1.32 | $308,880.00 |
DisclosureSEC source: 0001209191-19-030378 · doc4.xml · derivative · entry 1 Kocinsky Joseph · CIK 0001655595 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,000 Underlying: Stock Options · 234,000 shares Expires 2029-05-14 F1 · kind: Annual Equity Award: 25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. Read SEC document |
| February 20, 2019 Filed Feb 25, 2019 11:06 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 38,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-012815 · doc4.xml · nonDerivative · entry 1 Kocinsky Joseph · CIK 0001655595 · Corp VP, CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,517 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Restricted stock unit shall vest immediately, but the shares shall not be delivered until February 20, 2020. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 23:19 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option (right to buy) · Derivative | 37,525 | $1.42 Strike: $1.42 | $53,285.50 |
DisclosureSEC source: 0001209191-18-045603 · doc4.xml · derivative · entry 2 Kocinsky Joseph · CIK 0001655595 · Corp VP, CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,525 Underlying: Stock Options · 37,525 shares Expires 2027-05-25 F2 · kind: On May 25, 2017, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On August 2, 2018, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 23:19 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option (right to buy) · Derivative | 20,000 | $4.55 Strike: $4.55 | $91,000.00 |
DisclosureSEC source: 0001209191-18-045603 · doc4.xml · derivative · entry 1 Kocinsky Joseph · CIK 0001655595 · Corp VP, CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Stock Options · 20,000 shares Expires 2026-05-19 F1 · kind: On May 19, 2016, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On August 2, 2018, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| May 16, 2018 Filed May 18, 2018 14:15 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option (right to buy) · Derivative | 214,000 | $1.91 Strike: $1.91 | $408,740.00 |
DisclosureSEC source: 0001209191-18-031287 · doc4.xml · derivative · entry 1 Kocinsky Joseph · CIK 0001655595 · Corp VP, CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,000 Underlying: Stock Options · 214,000 shares Expires 2028-05-16 F1 · kind: 25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. Read SEC document |
| August 28, 2017 Filed Aug 30, 2017 01:07 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 353 | $1.55 | $547.15 |
DisclosureSEC source: 0001209191-17-050657 · doc4.xml · nonDerivative · entry 1 Kocinsky Joseph · CIK 0001655595 · Corp VP, CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,010 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 23:09 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 229 | $1.41 | $322.89 |
DisclosureSEC source: 0001209191-17-050012 · doc4.xml · nonDerivative · entry 2 Kocinsky Joseph · CIK 0001655595 · Corp VP, CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,363 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 23:09 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 212 | $1.46 | $309.52 |
DisclosureSEC source: 0001209191-17-050012 · doc4.xml · nonDerivative · entry 1 Kocinsky Joseph · CIK 0001655595 · Corp VP, CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,592 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.